GEM FORLAB S.r.L. is a company that continues the experience of ABLE Biosciences as a global provider of scientific technology and services to the Life Science industry. They offer solutions to companies of all sizes through three technology areas: Organic Chemistry, Mass Spectrometry & Proteomics, and Cell and Molecular Biology & Immunoassay. Founded in 2011 and headquartered in Italy, GEM FORLAB is a significant player in the field. Their parent company, ABLE Biosciences, is GLP certified and included in the OsSC register of Private Laboratories qualified to perform analysis on samples derived from drug clinical trials. The Chemistry Unit of GEM FORLAB provides essential components for early drug discovery, which includes synthesis of chemical intermediates, lead generation and optimization, bioconjugate chemistry, and molecules for molecular imaging techniques. With a strong foundation and a wide range of capabilities, GEM FORLAB holds potential for growth and innovation in the Life Science industry.
There is no investment information
No recent news or press coverage available for GEM FORLAB S.r.L..